Fatty Liver Treatment Market

Fatty Liver Treatment Market: Global Industry Analysis and Opportunity Assessment 2016-2026

  • Ongoing
  • July 2020
  • REP-GB-1369
Fatty Liver Treatment Market

  • US$5,000
  • US$7,500
  • US$10,000

This Fatty Liver Treatment market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Fatty Liver Treatment market.

Fatty liver disease is the most common liver dysfunction in which the triglyceride fat accumulates in liver cells. The fatty liver disease is caused due to obesity and excessive alcohol intake. Fatty liver is caused due to excessive alcohol intake known as Alcoholic Fatty Liver Disease (ALD) and obesity or insulin resistance known as Non-Alcoholic Liver Disease (NAFLD). The major risk factors associated with fatty liver disease are alcoholic cirrhosis, metabolic syndrome, biliary cirrhosis, progressive liver fibrosis and hepatocellular carcinoma (HCC) as well as increased cardiovascular disorder. Fatty liver disease is currently expected to be the leading cause of hepatocellular carcinoma. The technological advancements and the routine liver function tests are now resulting in the early detection of fatty liver treatment. The increase in incidence of fatty liver disease associated with excessive alcohol intake is expected to create an opportunity for the growth of fatty liver treatment market during the forecast period.

Fatty Liver Treatment Market: Drivers and Restraints

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact
The incidence rate of fatty liver disease particularly the Non-Alcoholic Liver Disease (NAFLD) was estimated to increase approximately by 20 to 25% in 2015. Thus, the market for fatty liver treatment is anticipated to grow significantly during the forecast period. The advancement in technology, personalized medicine, cost effective treatment procedures are few other factors predicted to fuel growth of global fatty liver treatment market. However, the side effects associated with the treatment, and increasing stringency in the regulatory requirements are some of the major factors limiting the growth of global fatty liver treatment market.

Fatty Liver Treatment Market: Segmentation

The global fatty liver treatment market has been classified on the basis of drugs, end use and geography.

Fatty Liver Treatment Market: Overview

Due to the availability of variety of agents for fatty liver treatment, the market for overall fatty liver treatment is expected to grow significantly. Additionally, the investment of pharmaceutical companies in the research and development are anticipated to contribute in the growth of fatty liver treatment market. In U.S. it is estimated that more than 15 Mn people are involved in the abuse or over abuse of alcohol and among them more than 90% people suffer from fatty liver disease. Thiazolidinedione and metformin are widely used for the Non-Alcoholic Liver Disease (NAFLD) caused due to insulin resistance. Thus, thiazolidinedione and metformin are expected to highly contribute in the growth of global fatty liver treatment market.

Fatty Liver Treatment Market: Regional Overview

Geographically, the global fatty liver treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APAC, Japan, Middle East and Africa. North America and Europe are expected to dominate the fatty liver treatment market due to abuse cases of alcoholic beverages. APAC is the fastest growing market with increasing prevalence of fatty liver disease associated with factors such as growing alcoholic intake, drug abuse and high prevalence of diabetes.  The global fatty liver treatment market is expected to grow remarkably during the forecast period due to increasinginvestment by multinational companies in the research and development.

Fatty Liver Treatment Market: Key Players

Some of the key players operating in this market are Cardax, Inc., Daewoong Co., Ltd., Hoffmann-La Roche Ltd., Glenmark. GW Pharmaceuticals, Limerick BioPharma, Inc., Merck & Co., Inc., Novartis AG, Orchid Chemicals & Pharmaceuticals Ltd, AstraZeneca.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Fatty Liver Treatment Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Based on drugs, the global fatty liver treatment market is divided into following:

  • Thiazolidinedione
  • Vitamin E
  • Metformin
  • Statins
  • Polyunsaturated fatty acids
  • Angiotensin receptor blockers
  • Pentoxifylline

Based on end user type, the global fatty liver treatment market is divided into following:

  • Hospitals
  • Clinics

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC countries, S. Africa, Rest Of MEA)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Fatty Liver Treatment Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Fatty Liver Treatment Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients

Request Sample Request customization Request Methodology